MMMarco Mravic

Marco Mravic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marco Mravic has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structural insights into DHODH-mediated catalysis and drug resistance

    by Ruchika Pokhriyal, Hyuk-Soo Seo, Mio Murakoso, Sonia E. Trojan, Laura Evans, Jillian K. O’Neil, Komal Chauhan, Shakchhi Joshi, Hanna Meyer, Anders Friberg, et al.

    Dihydroorotate dehydrogenase (DHODH), which catalyzes the rate-limiting step in de novo pyrimidine biosynthesis, is a validated therapeutic target in cancer, autoimmune disorders and infectious diseases. DHODH is hypothesized to utilize a ‘ping-pong’ catalytic mechanism. However, available crystal structures of DHODH in complex with small molecule inhibitors are irreconcilable with this model, showing simultaneous occupancy of both substrate binding sites. To elucidate the structural basis for DHODH-mediated catalysis, we resolved the structures of two DHODH holoenzymes. These structures capture novel conformational states that show mutually exclusive substrate binding. The holoenzyme structures also suggest that conformational changes in the catalytic loop of DHODH play a critical role in regulating enzyme activity. To map the functional landscape underlying DHODH inhibitor resistance, we performed deep mutational scanning drug-resistance screens with two clinically-relevant structurally distinct DHODH inhibitors, BAY2402234 and brequinar. Resistance variants cluster in the inhibitor binding site and at a previously unappreciated surface pocket on DHODH that allosterically regulates ubiquinone binding. Together, our findings provide structural evidence for the ‘ping pong’ model of catalysis, define the mutational landscape governing inhibitor resistance, and reveal novel structural vulnerabilities in DHODH that can be utilized for future drug development.

  • Open Access

    Programmed inhibition of an innate immune receptor via de novo designed transmembrane proteins

    by Colleen A. Maillie, Minghao Zhang, Nadia Gosiet, George Goldenfeld, Gerard J. Kroon, Andrew B. Ward, Marco Mravic

    Transmembrane domains of immune complexes transmit precise signals across lipid bilayers. Probing their interactions has the potential to yield mechanistic insights relevant to therapeutic design. However, our capability to generate molecules that bind lipid-embedded sites is limited. Here, we created synthetic polypeptides targeting a prominent mediator of inflammatory signaling directly within membranes, Toll-like receptor 4 (TLR4), and clarify structural principles of its cross-membrane signaling mechanism. Doing so, we test emerging design principles for computationally encoding protein interactions within lipid and validate a protein–protein interaction screening platform for rapid discovery of de novo transmembrane (TM) protein antagonist of inflammatory signaling via this innate immune receptor. Binding the TM domain of TLR4 poses a formidable de novo molecular recognition challenge not yet achieved, given the membrane-spanning region is predominantly apolar and lacks any recognizable interaction motifs (e.g., sticky small residue repeats). Likewise, TLR4’s structure–function relationship and key residues for oligomerization and cross-membrane signaling are underdetermined. Our engineering strategy identifies lead synthetic TM proteins that specifically bind TLR4’s transmembrane domain and antagonizes NFκB signaling in human cells. These transmembrane-directed chemical probes prove that receptor TM domain interaction geometries are essential for TLR4’s cross-membrane conformational coupling, informing a revised structural mechanism to leverage in future drug design of this protein family. This work refines principles for encoding stable interactions in cellular membranes and expands the range of lipid-embedded mechanisms accessible to probe with computationally derived molecules.

  • Open Access

    De novo design of transmembrane accessory subunits for fold stabilization and expansion

    by Sebastian Jojoa-Cruz, Saba Kanwal, Nolan P. Jacob, Weiyi Tang, Mio Murakoso, Minghao Zhang, Jiayi Li, Masy Domecillo, Nicholas F. Polizzi, John Robert Yates, et al.

    Transmembrane (TM) proteins play essential roles in biology as transporters, ion channels, chaperones, enzymes, and mediators of signal transduction. However, membrane proteins often suffer from inefficient folding and intrinsic instability. Misfolding in cells can cause numerous loss-of-function pathologies. Likewise, denaturation upon purification in the laboratory is a critical barrier to structure determination and characterization of key biochemical mechanisms. Generalizable strategies to stabilize membrane proteins remain limited. Here, we developed an informatics-based de novo design strategy to create synthetic auxiliary subunits that interact with the TM helices of a model pentameric ion channel, thereby bolstering folding while maintaining channel function. Biochemical and structural characterization reveal the synthetic TM subunits can also be used to create larger multi-spanning designer proteins of custom topology. This proof-of-concept motivates the feasibility of computationally designed accessory TM helices as potential pharmacological chaperone “folding correctors” of membrane proteins in disease and as tools in structural biology.

  • MemPPI platform for measuring and engineering membrane protein–protein interactions in mammalian cells via split nanoluciferase

    by Weiyi Tang, Sebastian Jojoa‐Cruz, Jiayi Li, George Goldenfeld, Marco Mravic

    Membrane protein–protein interactions (memPPIs) underlie critical biological processes including mediating signal transduction, transport, cell communication, and membrane organization. Despite their importance, systematic and quantitative measurement of protein transmembrane (TM) domains laterally interacting in mammalian cells remains challenging. Conventional fusion protein assays directed at memPPIs suffer from low dynamic range due to the crowded membrane environment and interference from overexpression, trafficking, or self‐complementation artifacts. Here, we assessed and further developed the split luciferase complementation NanoBit system to establish suitable expression constructs and working conditions for robust quantification of TM PPIs within human cells. We benchmarked the platform using a panel of natural and synthetic memPPI pairs with diverse architectures, insertion topologies, and trafficking patterns, finding assay settings that robustly distinguish true positive interactions from co‐expressed non‐interacting pairs. Adding a novel procedure measuring and normalizing protein expression levels in situ in parallel, we drastically improve assay dynamic range and consistency in discerning relative interaction propensities across broad expression levels—which also enhances compatibility with protein engineering screens. To extend measurements to versatile protein contexts, we developed membrane expression constructs and validated tagging strategies to improve trafficking with defined TM orientations. By incorporating topological control and accounting for variations in expression levels, this memPPI platform becomes a viable approach for high‐throughput interaction analyses and experimental screens for membrane protein design such as TM binders targeting human membrane proteins. Owing to its sensitivity, scalability, and adaptability, we expect this assay platform to have broad cross‐disciplinary utility in protein science, design, and drug discovery.


  • Open Access

    Design principles of the common Gly-X6-Gly membrane protein building block

    by Kiana Golden, Catalina Avarvarei, Charlie T. Anderson, Matthew Holcomb, Weiyi Tang, Xiaoping Dai, Minghao Zhang, Colleen A. Mailie, Brittany B. Sanchez, Jason S. Chen, et al.

    Protein behavior in lipids is poorly understood and inadequately represented in current computational models. Design and prediction abilities for bilayer-embedded molecular structures may be improved by characterizing membrane proteins’ most frequent, favored structural features to glean both context-specific and general principles. We used protein design to proactively interrogate the sequence–structure relationship and stabilizing atomic details of two highly prevalent antiparallel transmembrane (TM) motifs with Small-X 6 -Small consensus sequences. A fragment-based data-mining and sequence statistical inference method including cross-evolutionary structure-aligned covariance enabled engineering of de novo TM protein assemblies by successfully encoding Gly-X6-Gly and Ala-X6-Ala building blocks. A highly stable glycine-based design’s X-ray structure hosts Cα-H∙∙∙O = C H-bonding alongside extensive backbone-directed van der Waals packing, idealizing features of this motif in Nature. Data-driven design navigates sequence space to directly inquire upon how to encode and stabilize vital membrane protein structural elements, facilitating efficacious construction of lipid-embedded architectures of increasing complexity.


  • Open Access

    Design principles of the common Gly-X6-Gly membrane protein building block

    by Kiana Golden, Catalina Avarvarei, Charlie T. Anderson, Matthew Holcomb, Weiyi Tang, Xiaoping Dai, Minghao Zhang, Colleen A. Mailie, Brittany B. Sanchez, Jason S. Chen, et al.

    Protein behavior in lipid is poorly understood and inadequately represented in current computational models. Design and prediction abilities for bilayer-embedded molecular structures may be improved by characterizing membrane proteins’ most frequent, favored structural features to glean both context-specific and general principles. We used protein design to proactively interrogate the sequence-structure relationship and stabilizing atomic details of two highly prevalent antiparallel transmembrane (TM) motifs with Small-X 6 -Small consensus sequences. A fragment-based data-mining and sequence statistical inference method including cross-evolutionary structure-aligned covariance enabled engineering of de novo multi-span TM protein assemblies by successfully encoding Gly-X6-Gly and Ala-X6-Ala building blocks. A highly stable glycine-based design’s X-ray structure hosts Cα-H···O=C H-bonding alongside extensive backbone-directed van der Waals packing, idealizing features of this motif in Nature. Data-driven design navigates sequence space to directly inquiry upon how to encode and stabilize vital membrane protein structural elements, facilitating efficacious construction of lipid-embedded architectures of increasing complexity. Significance: Membrane proteins comprised of α-helices pack together within lipid bilayers, establishing stabilities and architectures that brace function and guide evolution. De novo design was used to clarify the consensus sequences and molecular features encoding of one exceedingly common TM helix packing architecture (∼10% of those in membrane folds). Small-X 6 -Small residue patterns were proven to reliably drive minimal proteins into these antiparallel TM geometries, revealing glycine mainchain hydrogen bonding or via fully apolar interfaces can encode the motif. Optimizing steric packing was the most decisive feature amongst the synthetic proteins. New membrane-specific design methods and model molecules are validated in route to outlining this important sequence-structure relationship broadly impacting the membrane proteome and revealing generalized structure-energetic imperatives governing interactions in lipid.


  • Open Access

    MemPPI platform for measuring and engineering membrane protein-protein interactions in mammalian cells via split nanoluciferase

    by Weiyi Tang, Sebastian Jojoa-Cruz, Jiayi Li, Marco Mravic

    Membrane protein–protein interactions (memPPIs) underlie critical biological processes including mediating signal transduction, transport, cell communication, and membrane organization. Despite their importance, systematic and quantitative measurement of protein transmembrane (TM) domains laterally interacting in mammalian cells remains challenging. Conventional fusion protein assays directed at memPPIs suffer from low dynamic range, due to the crowded membrane environment and interference from overexpression, trafficking, or self-complementation artifacts. Here, we assessed and further developed the split luciferase complementation NanoBit system to establish suitable expression constructs and working conditions for robust quantification of TM PPIs within human cells. We benchmarked the platform using a panel of natural and synthetic memPPI pairs with diverse architectures, insertion topologies, and trafficking patterns, finding assay settings that robustly distinguish true positive interactions from co-expressed non-interacting pairs. Adding a novel procedure measuring and normalizing protein expression levels in situ in parallel, we drastically improve assay dynamic range and consistency in discerning relative interaction propensities across broad expression levels – which also enhanced compatibility with protein engineering screens. To extend measurements to versatile protein contexts, we developed membrane expression constructs and validated tagging strategies to improve trafficking with defined TM orientations. By incorporating topological control and accounting for variations in expression levels, this memPPI platform becomes a viable approach for high-throughput interaction analyses and experimental screens for membrane protein design such as TM binders targeting human membrane proteins. Owing to its sensitivity, scalability, and adaptability, we expect this assay platform to have broad cross-disciplinary utility in protein science, design, and drug discovery.


  • Open Access

    Programmed inhibition of an innate immune receptor via de novo designed transmembrane proteins

    by Colleen A. Maillie, Minghao Zhang, Nadia Gosiet, George Goldenfeld, Andrew B. Ward, Marco Mravic

    Transmembrane domains of immune complexes transmit precise signals across lipid bilayers. Probing their interactions has the potential to yield mechanistic insights relevant to therapeutic design. However, our capability to generate molecules directed to bind lipid-embedded sites is limited. Here, we demonstrate a computational strategy to design polypeptides targeting Toll-like receptor 4 (TLR4), a mediator of inflammatory signaling, directly within membranes. TLR4 poses a formidable molecular recognition challenge, as its transmembrane domain is largely apolar, lacks a defined sequence motif, and exhibits an underdetermined structure–function relationship. One synthetic protein binds TLR4’s transmembrane domain and antagonizes NFκB signaling in human cells, proving that precise transmembrane domain interactions are essential for cross-membrane conformational coupling. This work refines design principles for encoding stable interactions in cellular membranes and expands the range of lipid-embedded mechanisms accessible to probe with computationally derived molecules.


  • Open Access

    Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations

    by Colleen A Maillie, Kiana Golden, Ian A Wilson, Andrew B Ward, Marco Mravic

    A potent class of HIV-1 broadly neutralizing antibodies (bnAbs) targets the envelope glycoprotein’s membrane proximal exposed region (MPER) through a proposed mechanism where hypervariable loops embed into lipid bilayers and engage headgroup moieties alongside the epitope. We address the feasibility and determinant molecular features of this mechanism using multi-scale modeling. All-atom simulations of 4E10, PGZL1, 10E8, and LN01 docked onto HIV-like membranes consistently form phospholipid complexes at key complementarity-determining region loop sites, solidifying that stable and specific lipid interactions anchor bnAbs to membrane surfaces. Ancillary protein-lipid contacts reveal surprising contributions from antibody framework regions. Coarse-grained simulations effectively capture antibodies embedding into membranes. Simulations estimating protein-membrane interaction strength for PGZL1 variants along an inferred maturation pathway show bilayer affinity is evolved and correlates with neutralization potency. The modeling demonstrated here uncovers insights into lipid participation in antibodies’ recognition of membrane proteins and highlights antibody features to prioritize in vaccine design.


  • Open Access

    Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations

    by Colleen Maillie, Jay Golden, Ian A Wilson, Andrew B Ward, Marco Mravic

    Summary A potent class of HIV-1 broadly neutralizing antibodies (bnAbs) targets the envelope glycoprotein’s membrane proximal exposed region (MPER) through a proposed mechanism where hypervariable loops embed into lipid bilayers and engage headgroup moieties alongside the epitope. We address the feasibility and determinant molecular features of this mechanism using multi-scale modeling. All-atom simulations of 4E10, PGZL1, 10E8 and LN01 docked onto HIV-like membranes consistently form phospholipid complexes at key complementarity-determining region loop sites, solidifying that stable and specific lipid interactions anchor bnAbs to membrane surfaces. Ancillary protein-lipid contacts reveal surprising contributions from antibody framework regions. Coarse-grained simulations effectively capture antibodies embedding into membranes. Simulations estimating protein-membrane interaction strength for PGZL1 variants along an inferred maturation pathway show bilayer affinity is evolved and correlates with neutralization potency. The modeling demonstrated here uncovers insights into lipid participation in antibodies’ recognition of membrane proteins and highlights antibody features to prioritize in vaccine design.